Bioptigen
Durham
About Bioptigen
Bioptigen Inc. is an ISO 13485-certified medical device company that develops innovative ophthalmic imaging solutions. Bioptigen’s Envisu(tm) R-class systems are ideally suited to non-invasive ophthalmic imaging of animals ranging from zebrafish to elephants. Using low-power, near-infrared light, Envisu generates real-time, high-resolution, volumetric images of ocular microstructures from the cornea to the retina. Bioptigen has received CE approval to market its hand-held Envisu R2000 systems for preclinical use and C2000 systems for clinical use within the EU.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $1.5M
- Funding stage: M&A
- Last round: Series Unknown (Mar 2011)
- Website: bioptigen.com
- Phone: 9193145501
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/bioptigen-2442916 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.